| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/SLA.0B013E31815FA447 |
| P698 | PubMed publication ID | 18376194 |
| P50 | author | John M. Luk | Q42935545 |
| P2093 | author name string | Xiao-Min Yu | |
| Chung-Yau Lo | |||
| Alfred King-Yin Lam | |||
| Pauline Leung | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| lymph node | Q170758 | ||
| P304 | page(s) | 483-489 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Annals of Surgery | Q4767866 |
| P1476 | title | Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma | |
| P478 | volume | 247 |
| Q38155724 | B-Raf mutation: a key player in molecular biology of cancer. |
| Q42759907 | Changes and prognostic value of serum vascular endothelial growth factor in patients with differentiated thyroid cancer |
| Q44018872 | Contrast-enhanced ultrasonography features of papillary thyroid carcinoma for predicting cervical lymph node metastasis |
| Q36465664 | Decreased serum level and increased urinary excretion of vascular endothelial growth factor-C in patients with chronic kidney disease |
| Q38843403 | Efficacy of lenvatinib in treating thyroid cancer. |
| Q34914923 | Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis |
| Q37571729 | Irinotecan therapy and molecular targets in colorectal cancer: a systemic review |
| Q38729953 | Lenvatinib: A Review in Refractory Thyroid Cancer |
| Q60959654 | Liposomal Delivery of miR-34b-5p Induced Cancer Cell Death in Thyroid Carcinoma |
| Q35575870 | Lymphangiogenesis and hemangiogenesis: potential targets for therapy |
| Q93048684 | MiRNAs Are Involved in Tall Cell Morphology in Papillary Thyroid Carcinoma |
| Q34714310 | Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation |
| Q92186667 | Preoperative serum VEGF-C but not VEGF-A level is correlated with lateral neck metastasis in papillary thyroid carcinoma |
| Q33894207 | Prophylactic uses of integrin CD18-betaA peptide in a murine polymicrobial peritonitis model |
| Q38237787 | Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis. |
| Q44776136 | Serum VEGF and VEGF-C values before surgery and after postoperative treatment in gastric cancer. |
| Q53165141 | Serum vascular endothelial growth factor-C combined with multi-detector CT in the preoperative diagnosis of lymph node metastasis of gastric cancer. |
| Q26751274 | Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives |
| Q47149651 | Structural alterations in tumor-draining lymph nodes before papillary thyroid carcinoma metastasis |
| Q58805425 | The role of palbociclib in thyroid carcinoma with BRAF mutation |
| Q36589860 | The role of the VEGF-C/VEGFRs axis in tumor progression and therapy |
| Q38694209 | The roles of microRNA-34b-5p in angiogenesis of thyroid carcinoma. |
| Q35930638 | VEGF-C Is a Thyroid Marker of Malignancy Superior to VEGF-A in the Differential Diagnostics of Thyroid Lesions |
| Q54291391 | VEGF-D and A Preoperative Serum Levels Predict Nodal and Distant Metastases in Differentiated Thyroid Cancer Patients. |
| Q51024629 | Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma. |
Search more.